Translational Diagnostics Core The long-term goal of the Washington University Diabetes Research Center (DRC) Translational Diagnostics Core is to improve human health by supporting clinical laboratory testing services for research in diabetes mellitus and related metabolic disorders. Most Core analyses are performed on samples from human studies and some are performed on samples from animal models. The Core provides expert consultation to investigators so that the most appropriate tests can be chosen while taking cost and number of samples into consideration. In addition to quantification of classic metabolic analytes relevant to diabetes, such as insulin and glucagon, the core also offers assays for diabetes and metabolism relevant molecules, such as adiponectin and TNF?. For some special analytes, the Core maintains contracts with Quest Diagnostics and Mayo Medical Laboratories, so that these analyses can be performed at substantially lower cost to DRC members. Development of new research tests is another important activity of the Translational Diagnostics Core, which makes available to DRC members analyses with enhanced sensitivity and accuracy that incorporate the latest advances in diabetes and metabolism research. The Translational Diagnostics Core provides efficient, high quality diagnostic services promoting the translation of basic scientific discoveries for the prevention, treatment and cure of diabetes and its complications. .

Public Health Relevance

Translational Diagnostics Core The Washington University Diabetes Research Center Translational Diagnostics Core performs efficient clinical laboratory testing to support research in the field of diabetes mellitus. The primary goals of the Core are to reduce the high costs of specialty testing and to provide outstanding quality control so that reliable diabetes- related tests are widely available to investigators focused on the pathogenesis, treatment and cure of diabetes and related metabolic disorders.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Saint Louis
United States
Zip Code
Adams, Melissa T; Gilbert, Jennifer M; Hinojosa Paiz, Jesus et al. (2018) Endocrine cell type sorting and mature architecture in the islets of Langerhans require expression of Roundabout receptors in ? cells. Sci Rep 8:10876
Funk, Steven D; Bayer, Raymond H; Malone, Andrew F et al. (2018) Pathogenicity of a Human Laminin ?2 Mutation Revealed in Models of Alport Syndrome. J Am Soc Nephrol 29:949-960
Bumpus, Emily; Hershey, Tamara; Doty, Tasha et al. (2018) Understanding activity participation among individuals with Wolfram Syndrome. Br J Occup Ther 81:348-357
Jung, Sang-Hee; Jung, Chan-Hee; Reaven, Gerald M et al. (2018) Adapting to insulin resistance in obesity: role of insulin secretion and clearance. Diabetologia 61:681-687
De Silva, Gayan S; Saffaf, Khalid; Sanchez, Luis A et al. (2018) Amputation stump perfusion is predictive of post-operative necrotic eschar formation. Am J Surg 216:540-546
Park, Sun-Ji; Kim, Yeawon; Chen, Ying Maggie (2018) Endoplasmic reticulum stress and monogenic kidney diseases in precision nephrology. Pediatr Nephrol :
Smith, Gordon I; Commean, Paul K; Reeds, Dominic N et al. (2018) Effect of Protein Supplementation During Diet-Induced Weight Loss on Muscle Mass and Strength: A Randomized Controlled Study. Obesity (Silver Spring) 26:854-861
Owuor, Theresa O; Reid, Michaela; Reschke, Lauren et al. (2018) Maternal obesogenic diet induces endometrial hyperplasia, an early hallmark of endometrial cancer, in a diethylstilbestrol mouse model. PLoS One 13:e0186390
Turecamo, S E; Walji, T A; Broekelmann, T J et al. (2018) Contribution of metabolic disease to bone fragility in MAGP1-deficient mice. Matrix Biol 67:1-14
Lin, Jonathan B; Moolani, Harsh V; Sene, Abdoulaye et al. (2018) Macrophage microRNA-150 promotes pathological angiogenesis as seen in age-related macular degeneration. JCI Insight 3:

Showing the most recent 10 out of 654 publications